CY2024 Q1
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| Future FinTech Group Inc. | $980,000.00 | 2024-04-16 | View |
| Citius Pharmaceuticals, Inc. | $8,906,815.00 | 2024-03-31 | View |
| ADIAL PHARMACEUTICALS, INC. | $56,792.00 | 2024-04-10 | View |
| ACTAVIA LIFE SCIENCES, INC. | $4,645.00 | 2024-03-31 | View |
| 180 LIFE SCIENCES CORP | $2,270,000.00 | 2024-04-16 | View |
| VIRPAX PHARMACEUTICALS, INC. | $1,845,260.00 | 2024-03-27 | View |
| BiomX Inc. | $1,500,000.00 | 2024-03-15 | View |
| ELEVAI LABS INC. | $400,000.00 | 2024-04-30 | View |
| NORTHVIEW ACQUISITION CORP. | $59,867.00 | 2024-02-16 | View |
| CYNGN INC. | $2,884.00 | 2024-05-08 | View |
| VERSES AI INC. | $234,087.00 | 2024-04-18 | View |
| SOLIDION TECHNOLOGY, INC. | $669,985.00 | 2024-04-29 | View |
| NATURE’S MIRACLE HOLDING INC. | $42,500.00 | 2024-05-02 | View |
| INFLECTION POINT ACQUISITION CORP. II | $27,083.00 | 2024-03-28 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations